JUST Leveled Up

Watch video


Turning cancer on
itself > Finally

SCINTIX therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.


Cancer is talking.
We’re listening.

When radiopharmaceuticals are introduced into the body, cancer cells absorb them and create a biological beacon, which our machine uses to manage motion and treat solid tumors of any stage disease.

Learn About Emissions

Targeting Cancer


Our SCINTIX technology delivers high doses of radiation to tumors, even those in motion. Live targeting allows for greater impact to the tumor and potentially less dose to surrounding tissues.

Learn About Targeting


A world where stage
is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy. Our breakthrough SCINTIX therapy creates a new option for patients with lung or bone tumors arising from primary or metastatic cancer.

Discover the Potential

Combination Treatment

Come at cancer
from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. Adding SCINTIX therapy to chemotherapy, immunotherapy and targeted drugs may potentially improve outcomes.

Learn About Treatment

Learn more about our breakthrough technology

SCINTIX Biology-guided Radiotherapy

By combining PET-CT and radiotherapy, we're able to find and treat cancer using emissions created by tumors themselves.


Discover SCINTIX therapy.

Cancer Centers

See how SCINTIX therapy can play a role
in your cancer program.

Make every day count

See Available Positions


Press Releases

RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers Including Brain, Pancreatic and Liver

New molecule to enable RefleXion’s SCINTIX therapy to treat most solid tumors HAYWARD, Calif., and BERLIN, Sept. 20, 2023 – RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop […]

View All Press chevron right


Science fiction becomes reality, and a new day dawns for cancer care

It sounds like the stuff of science fiction: a technology that can detect the biological activity of cancer cells in the body and direct targeted beams of energy to destroy tumors in real-time. That vision is now a reality, and with it, a new day has dawned for cancer care. The milestone moment occurred in […]

View All Blog Posts chevron right


Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up